Join A&M Healthcare Industry Group's Marthe Haverkamp, M.D., Ph.D, as she sits down with world-renowned virologist Ab Osterhaus, Ph.D., and vaccine expert Manon Cox, Ph.D., MBA, Chief Executive Officer and Co-Founder of NextWaveBio. They discuss the future of vaccines, the value of COVID-19 treatments, and the influence of Omicron on the pandemic: Is a relatively mild disease now a comparative advantage for the future?
https://www.alvarezandmarsal.com/insights/is-omicron-our-way-out
Cristina Inglese, Executive Director, Commercial Products, is an inspiring member of L.A. Care Health Plan’s leadership team. She is dedicated to making a positive...
In A&M Healthcare Industry Group’s two-part Podcast Series, ‘The Impact of the Current Nursing Shortage on U.S. #Healthcare Organizations', we sit down with three...
The recent rise in labor costs is impacting operations for U.S. healthcare organizations. Listen to A&M Healthcare Industry Group's latest podcast to learn how...
